Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KANSL1L antisense RNA 1 (KANSL1L-AS1) is a long non-coding antisense RNA gene transcribed from chromosome 2 (chromosomal location 2:210,030,572-210,064,356 according to Ensembl). It is an RNA gene and does not encode a protein; its function, disease role, and mechanisms have not been characterized in current public databases. There is no evidence it functions as a therapeutic target or is implicated in clinical biomarker applications or drug interactions. If you require information about the neighboring protein-coding gene (KANSL1L), or the related protein-coding KANSL1 gene, those are distinct entities and should be considered separately.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KANSL1L antisense RNA 1 (KANSL1L-AS1).